Key facts
- It has raised $39.1M; the latest was Later Stage VC ($31.5M) in Feb 2026.
- Notable investors include Athletic Ventures ( Australia ), Spectrum Equity, Equity Venture Partners, South Australian Government.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Splose
- ·The full record, as it builds
Funding rounds
No funding rounds for Splose are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Splose
Developer of a practice management software designed to improve and embrace the power of artificial intelligence and automation to give healthcare professionals. The company's software offers services that include automated client onboarding, scheduling team appointments, case management, invoicing and payments, practice automation, and business intelligence reporting, enabling allied health and NDIS providers to set up workflows that improve every stage of the client journey, leverage insights from reports, and build and customize templates that power up their business.
- Sector
- Healthcare
- HQ
- Adelaide, Australia
- Founded
- 2016
- Employees
- 77
- Website
- splose.com/
- Ownership
- Privately Held (backing)
Splose doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Splose shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Splose in its N-PORT filings yet. We sweep new filings monthly.